Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children
Clinical trial NCT02308527 · COMPLETED
Trial details
- NCT number
- NCT02308527
- Sponsor
- University of Birmingham
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2021-08-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.